Loading publications…
The last 5 uploaded publications
The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential
Miriam Verdú-Bou, Maria João Baptista, Marcelo Lima Ribeiro, Aleix Méndez López, Núria Profitós-Pelejà, Fabian Frontzek, Gaël Roué, José Luís Mate, M. Pellicer, Pau Abrisqueta, Josep Castellví, Mariana Bastos‐Oreiro, Javier Menárguez, Miguel Alcoceba, Eva González‐Barca, Fina Climent, Antonio Salar, Juan‐Manuel Sancho, Annette M. Staiger, German Ott, Ioannis Anagnostopoulos, Manel Esteller, Georg Lenz, Gustavo Tapia, José‐Tomás Navarro (2025). The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential. , DOI: https://doi.org/10.1182/bloodadvances.2025016180.
Article74 days agoExtramedullary multiple myeloma patient derived orthotopic xenograft with high disturbed genome: combined exhaustive molecular and therapeutic studies
Lourdes Farré, Gabriela Sanz‐Linares, Neus Ruiz‐Xivillé, Manuel Castro de Moura, Juan Francisco Martín Tejera, Samuel Gonçalves-Ribeiro, María Martínez‐Iniesta, Mónica Calaf, José Luis Mosquera, José I. Martı́n-Subero, Isabel Granada, Manel Esteller, Eva Domingo‐Domènech, Fina Climent, Alberto Villanueva, Anna Sureda (2021). Extramedullary multiple myeloma patient derived orthotopic xenograft with high disturbed genome: combined exhaustive molecular and therapeutic studies. , 14(7), DOI: https://doi.org/10.1242/dmm.048223.
Article74 days agoEpigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome
Rosaura Esteve‐Puig, Fina Climent, David Piñeyro, Eva Domingo‐Domènech, Verónica Dávalos, Maite Encuentra, Anna Rea, Nadia Espejo‐Herrera, Marta Soler, Miguel López, Vanessa Ortiz-Barahona, Gustavo Tapia, José‐Tomás Navarro, Joan Cid, Lourdes Farré, Alberto Villanueva, Isolda Casanova, Ramón Mangues, Pablo Santamarina‐Ojeda, Agustín F. Fernández, Mario F. Fraga, Miguel Á. Piris, Nitzan Kol, Chen Avrahami, Sharon Moshitch-Moshkovitz, Gideon Rechavi, Anna Sureda, Manel Esteller (2020). Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome. , 137(7), DOI: https://doi.org/10.1182/blood.2020005823.
Letter74 days agoEpigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome
Rosaura Esteve‐Puig, Fina Climent, David Piñeyro, Eva Domingo‐Domènech, Verónica Dávalos, Maite Encuentra, Anna Rea, Nadia Espejo‐Herrera, Marta Soler, Miguel López, Vanessa Ortiz-Barahona, Gustavo Tapia, José‐Tomás Navarro, Joan Cid, Lourdes Farré, Alberto Villanueva, Isolda Casanova, Ramón Mangues, Pablo Santamarina‐Ojeda, Agustín F. Fernández, Mario F. Fraga, Miguel Á. Piris, Nitzan Kol, Chen Avrahami, Sharon Moshitch-Moshkovitz, Gideon Rechavi, Anna Sureda, Manel Esteller (2020). Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome. , 137(7), DOI: https://doi.org/10.1182/blood.2020005823.
Letter74 days agoResistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
Jorge Gómez‐Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Héctor Perez‐Montoyo, Ana Igea, Purificacı́on Muñoz, Manel Esteller, Ángel R. Nebreda, Ander Urruticoechea, Idoia Morilla, Sònia Pernas, Fina Climent, María Teresa Soler-Monsó, Ana Petit, Violeta Serra, Aleix Prat, Eva González‐Suárez (2017). Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population. , 8(5), DOI: https://doi.org/10.1016/j.stemcr.2017.03.026.
Article74 days ago